Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys to Acquire SciTegic for $21.5M in Cash and Stock

NEW YORK, Sept. 14 (GenomeWeb News) - Accelrys plans to acquire SciTegic, a provider of workflow software for research, for about $21.5 million in cash and stock, the company said today.

 

San Diego-based SciTegic will become a wholly-owned subsidiary of Accelrys, which plans to incorporate SciTegic's Pipeline Pilot software into its portfolio.

 

Shareholders of SciTegic will receive $12.25 million of cash and approximately one million shares of Accelrys common stock in exchange for their SciTegic shares at closing, and about 300,000 additional Accelrys shares over the next two years. The acquisition is subject to approval by SciTegic shareholders and is expected to close this month.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.